How to buy Cencora stock (COR)

Cencora is a medical distribution business based in the US. Cencora shares (COR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $227.54 – a decrease of 0.04% over the previous week. Cencora employs 46,000 staff and has a trailing 12-month revenue of around $294 billion.

Our top picks for where to buy Cencora stock

Buy Cencora stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Cencora stock price (NYSE: COR)

Use our graph to track the performance of COR stocks over time.

Cencora shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$227.54
52-week range	$200.47 - $253.27
50-day moving average more info button	$238.25
200-day moving average more info button	$233.82
Wall St. target price	$266.34
PE ratio more info button	30.1048
Dividend yield more info button	$2.04 (0.97%)
Earnings per share (TTM) more info button	$7.54

Is it a good time to buy Cencora stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cencora price performance over time

Historical closes compared with the close of $227.64 from 2024-12-23

1 week (2024-12-18)	0.29%
1 month (2024-11-25)	-6.79%
3 months (2024-09-25)	1.88%
6 months (2024-06-25)	-4.49%

1 year (2023-12-22)	12.12%
2 years (2022-12-23)	36.60%
3 years (2021-12-23)	81.54%
5 years (2019-12-24)	184.48%

Is Cencora stock undervalued or overvalued?

Valuing Cencora stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cencora's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cencora's P/E ratio

Cencora's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Cencora shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Cencora's PEG ratio

Cencora's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cencora's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Cencora's EBITDA

Cencora's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 billion.

The EBITDA is a measure of a Cencora's overall financial performance and is widely used to measure a its profitability.

Cencora financials

Revenue TTM	$294 billion
Operating margin TTM	0.85%
Gross profit TTM	$8.3 billion
Return on assets TTM	3.1%
Return on equity TTM	209.12%
Profit margin	0.51%
Book value	$4.01
Market Capitalization more info button	$43.9 billion

TTM: trailing 12 months

Cencora share dividends

Dividend payout ratio: 15.12% of net profits

Recently Cencora has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cencora shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Cencora's case, that would currently equate to about $2.04 per share.

While Cencora's payout ratio might seem low, this can signify that Cencora is investing more in its future growth.

Cencora's most recent dividend payout was on 28 November 2024. The latest dividend was paid out to all shareholders who bought their shares by 14 November 2024 (the "ex-dividend date").

Have Cencora's shares ever split?

Cencora's shares were split on a 2:1 basis on 15 June 2009 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cencora shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cencora shares which in turn could have impacted Cencora's share price.

Cencora share price volatility

Over the last 12 months, Cencora's shares have ranged in value from as little as $200.4744 up to $253.27. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cencora's is 0.436. This would suggest that Cencora's shares are less volatile than average (for this exchange).

Cencora overview

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U. S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry.

Frequently asked questions

null
What percentage of Cencora is owned by insiders or institutions?
Currently 10.719% of Cencora shares are held by insiders and 93.702% by institutions. How many people work for Cencora?
Latest data suggests 46,000 work at Cencora. When does the fiscal year end for Cencora?
Cencora's fiscal year ends in September. Where is Cencora based?
Cencora's address is: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 What is Cencora's ISIN number?
Cencora's international securities identification number is: US03073E1055 What is Cencora's CUSIP number?
Cencora's Committee on Uniform Securities Identification Procedures number is: 03071P102